Targeting Mitochondria 2017 at a glance

Among Speakers and Topics already confirmed:

Part 1: Targeting Mitochondria 2017: Recent Advances on Mitochondrial Dysfunctions in Chronic Diseases: The Mechanistic

Targeting mitochondria by small RNAs: update and prospects
Ivan Tarassov, University of Strasbourg, France

Hydrogen sulfide and mitochondrial function
Csaba Szabo,
University of Texas, USA

Mitochondrial ROS mediated signaling pathways: activation and regulation upon inflammation
Andrey Kozlov, L. Boltzmann Institute für experimentelle und klinische Traumatologie, Austria

Mitochondria and Alzheimer’s disease
Natalia Stefanova, Institute of Cytology and Genetics, Russia
 
Mitochondrial ROS and longevity: Recent scientific advances
Ana Lechuga-Vieco, Fundación Centro Nacional de Investigaciones Cardiovasculares, Spain
 
Regulation of cardiac excitation-contraction-bioenergetics coupling by mitochondrial fission protein Drp1
Shey-Shing Sheu, Thomas Jefferson University, USA
 
Mitochondria: a switchboard between various cell death modalities
Vladimir Gogvadze, Karolinska Institute, Sweden
 
Part 2: How to Evaluate Mitochondria Function/Dysfunction?

Probing Mitochondrial Chemical Biology with Organelle-Specific Peptides
Shana O'Kelley, 
University of Toronto, Canada

Testing the therapeutic potential of antioxidants in diverse disease models
Marten Szibor, University of Helsinki, Finland

High-content mitochondrial analysis by live-cell microscopy
Werner Koopman, Radboudumc University, The Netherlands

Part 3: Strategies to target Mitochondria: Recent Clinical & Potential Therapeutic Studies

Mitochondria-targeted rechargeable antioxidants as pharmaceuticals inhibiting the aging program in humans
Maxim Skulachev, Moscow State University, Russia

The impact of mitochondria-targeted antioxidants on cancer progression
Martin Bergö, Sahlgrenska Cancer Center, Sweden

Prevention of mitochondrial disease transmission
Yuko Takeda, The Newcastle University, United Kingdom

Polymeric nanoparticle-based mitochondria-targeting systems
Han Chang Kang, The Catholic University of Korea, The Republic of Korea

mtDNA induced inflammatory response in lungs: recent scientific advances
Bartosz Szczesny, University of Texas Medical Branch at Galveston, USA

iPSC-based drug discovery for neurological mitochondrial disease
Alessandro Prigione, Max Delbrueck Center for Molecular Medicine, Germany

Assessing the delivery of molecules to the mitochondrial matrix using click chemistry
Kurt Hoogewijs, The Wellcome Trust Centre for Mitochondrial Research, Newcastle University, United Kingdom

Vitamin B3 supplementation trial for mitochondrial myopathy
Eija Pirinen, University of Helsinki, Finland 

Human mitochondrial leucyl tRNA synthetase can suppress non cognate pathogenic mt-tRNA mutations
Hue-Tran Hornig-Do, University of Cologne, Germany  

Mitochondria targeted diagnostic and photodynamic therapy
Sabyasachi Chakrabortty, Max Planck Institute, Germany
 
 

 

 
Day 1  - October 23, 2017
07h30 - 9h00 Registration & Welcoming
08h55 Welcome Address
09h00 - 11h00 Targeting Mitochondria 2017: Recent Advances on Mitochondrial Dysfunctions in Chronic Diseases: The Mechanistic
(Part I)
11h00 - 11h30 Coffee Break & Poster Session
11h30 - 12h30 Short Oral Presentations
12h30 - 14h00 Lunch Break & Poster Session
14h00 - 16h00 How to Evaluate Mitochondria Function/Dysfunction?
16h00 - 16h30 Coffee Break & Poster Session
16h30 - 17h30 Short Oral Presentations
17h30  End of the first day
20h00

Targeting Mitochondria Dinner

To participate, please register online before October 9

 


 

 
Day 2 - October 24, 2017
08h55 Opening of the second day
09h00 - 10h30

Strategies to target Mitochondria: Recent Clinical & Potential Therapeutic Studies (Part I)

10h30 - 11h00 Coffee Break & Poster Session
11h00 - 12h30 Strategies to target Mitochondria: Recent Clinical & Potential Therapeutic Studies (Part II)
12h30 - 14h00 Lunch Break & Poster Session
14h00 - 15h30 Short Oral Presentations (Part I)
15h30 - 16h15 Coffee Break & Poster Session
16h15 - 17h00 Short Oral Presentations (Part II)
17h15 - 18h00

Conclusion of Targeting Mitochondria 2017

Targeting Mitochondria Awards

18h00  End of tTargeting Mitochondria 2017